CClinicalTrials.gg
CompletedNCT01159184Updated Mar 27, 2012

Stressors, Coping Methods and Social Support in Diabetic Patients

An observational study in Type 2 Diabetes, sponsored by Far Eastern Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2012-03-27.

Sponsored by Far Eastern Memorial Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
301
Ages
30 Years to 80 Years
Sex
All
01

Study summary

The increasing prevalence of diabetes brought great burden to health status of the investigators population. It is meaningful to investigate the stressor, stress perceived, social support and coping methods in diabetic population in order to provide appropriate assistance to these patients. This study will recruit diabetes patients from out-patient-department and they are invited to complete a questionnaire. The contents of the questionnaire including stress experienced, stress perceived, social support and coping methods. The investigators purpose is to find out the impact of these factors on glycemic controlled and their life quality. The results will be useful to diabetes care team when health education is delivered to patient.

Read the detailed description

Type 2 diabetes patient aged 30-80 y/o under oral hypoglycemic agents with clear conscious enable to answer questions properly who regularly follow up at our metabolism clinic is eligible. Patients are asked to complete a questions containing basic personal information, diabetes coping method Chinese version (DCM-C)questionnaire, social support and perceived stress scale.

02

Conditions studied

  • Type 2 Diabetes

Keywords

  • stress
  • coping methods
  • social support
  • diabetes mellitus
03

In context

Lead sponsor

Far Eastern Memorial Hospital is the lead sponsor of 253 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  1. Type 2 diabetes
  2. Aged 30-80 year old
  3. under oral hypoglycemic agents
  4. clear consciousness

Inclusion criteria

  1. Type 2 diabetes
  2. Aged 30-80 year old
  3. under oral hypoglycemic agents
  4. clear consciousness

Exclusion criteria

Exclusion Criteria:

  1. Type 1 diabetes
  2. Age below 30 and above 80
  3. Insulin use
  4. Conscious not clear
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
301 participants (actual)
06

Study locations

1 site
  • Far Eastern Memorial Hospital
    Banciao, Taipei county 22060, Taiwan
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01159184
Lead sponsor
Far Eastern Memorial Hospital
Responsible party
Ju-Ying Jiang (Attending physician, Far Eastern Memorial Hospital) — Principal investigator
First posted
Jul 9, 2010
Start date
Jan 2010
Primary completion
Dec 2011
Completion
Dec 2011
Last update
Mar 27, 2012

Study contacts

Ju Ying Jiang, MD
principal investigator · Far Eastern Memorial Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion